The problem
Each year, 10 million severe stroke patients are picked up by ambulances around the world. Half of these stroke patients that can be treated with endovascular treatment, but are brought to hospitals that do not have endovascular treatment. This results in an average delay of endovascular treatment of 90 minutes, which leads to seriously worsened disease outcomes and a larger burden on society.
Our solution
With StrokePointer from TrianecT, we combine brain activity measurement and artificial intelligence to detect these treatable stroke patients in the ambulance and bring them directly to their best treatment. This saves time and time = brain.
Our Team
Dr. Wouter Potters
CEO, Co-founder
Dr. Jonathan Coutinho
Co-founder
Dr. Henk Marquering
Co-founder
Dr. Frank Zanow
Co-founder
Our partners
2018
Amsterdam Science & Innovation Award
2021
First clinical trial results
2022
TrianecT incorporated
Do you want to join our mission to improve acute stroke care?
Then connect with us at letsmeet@trianect.com
Careers
Are you a talented and self-driven student looking for an internship? Do you want to take on a challenge in our young and dynamic start-up? We welcome internship applications of excellent candidates (for example on marketing, sales, medical software development or UX design). Make sure to attach your curriculum vitae and your motivation letter when applying.
Apply at internship@trianect.com
